These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Nanocarriers for anticancer drugs--new trends in nanomedicine. Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925 [TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Polymeric Nanosystems for Treating Cutaneous Melanoma and Its Metastasis. Chou YP; Lin YK; Chen CH; Fang JY Curr Pharm Des; 2017; 23(35):5301-5314. PubMed ID: 28699537 [TBL] [Abstract][Full Text] [Related]
8. Delivery and targeting of nanoparticles into hair follicles. Fang CL; Aljuffali IA; Li YC; Fang JY Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342 [TBL] [Abstract][Full Text] [Related]
9. Nanoparticles as delivery carriers for anticancer prodrugs. Fang JY; Al-Suwayeh SA Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134 [TBL] [Abstract][Full Text] [Related]
10. Dendronized Systems for the Delivery of Chemotherapeutics. Dockery L; Daniel MC Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108 [TBL] [Abstract][Full Text] [Related]
11. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723 [TBL] [Abstract][Full Text] [Related]
12. Nanoparticles for Cancer Targeting: Current and Future Directions. Swain S; Sahu PK; Beg S; Babu SM Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485 [TBL] [Abstract][Full Text] [Related]
13. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency. Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520 [TBL] [Abstract][Full Text] [Related]
14. Nano-Based Drug Delivery or Targeting to Eradicate Bacteria for Infection Mitigation: A Review of Recent Advances. Yeh YC; Huang TH; Yang SC; Chen CC; Fang JY Front Chem; 2020; 8():286. PubMed ID: 32391321 [TBL] [Abstract][Full Text] [Related]
15. Application of chitosan-based nanocarriers in tumor-targeted drug delivery. Ghaz-Jahanian MA; Abbaspour-Aghdam F; Anarjan N; Berenjian A; Jafarizadeh-Malmiri H Mol Biotechnol; 2015 Mar; 57(3):201-18. PubMed ID: 25385004 [TBL] [Abstract][Full Text] [Related]
16. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. Torchilin VP AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355 [TBL] [Abstract][Full Text] [Related]
17. Nanomedicine for Treatment of Lung Cancer. Hussain S Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803 [TBL] [Abstract][Full Text] [Related]
18. Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends. Sohail MF; Rehman M; Sarwar HS; Naveed S; Salman O; Bukhari NI; Hussain I; Webster TJ; Shahnaz G Int J Nanomedicine; 2018; 13():3145-3161. PubMed ID: 29922053 [TBL] [Abstract][Full Text] [Related]
19. Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer. Kumar L; Baldi A; Verma S; Utreja P Pharm Nanotechnol; 2018; 6(2):94-110. PubMed ID: 29866028 [TBL] [Abstract][Full Text] [Related]
20. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics. Huang D; He B; Mi P Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]